360 High-Risk Vulnerability Immunization Tool V2.0 is a commercial endpoint protection platform solution by 360 Security Group (Qihoo 360). Zentara AVAS is a commercial vulnerability assessment solution by Zentara. Features, integrations, deployment and the company behind each one, side by side.
Tool that immunizes Windows systems against critical vulnerabilities
See more solutions in this category, or build a security stack from your picks.
Based on what each listing shows: deployment, company size, price and open source.
360 High-Risk Vulnerability Immunization Tool V2.0 fits if you need to run it on your own servers and you are a startup.
Zentara AVAS fits if you want a cloud product.
Common questions when comparing 360 High-Risk Vulnerability Immunization Tool V2.0 vs Zentara AVAS for endpoint protection platform.
360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. Built by 360 Security Group (Qihoo 360).
Zentara AVAS: Built by Zentara.
The table above shows where their features, integrations, deployment and company size fit differ.
360 High-Risk Vulnerability Immunization Tool V2.0 is made by 360 Security Group (Qihoo 360). Zentara AVAS is made by Zentara. The vendor behind a product decides its roadmap, support, and longevity, so check each company's profile before you commit.
In part. 360 High-Risk Vulnerability Immunization Tool V2.0 and Zentara AVAS are not in the same category on CybersecTools. Both cover CVE, Zero Day. Use the table above to see where features, deployment and company size fit differ.
No Endpoint Protection Platform shortlist yet. This is the closest one.
Updated 2026-11-01
See the shortlist